Correlation Between Lucy Scientific and Evoke Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lucy Scientific and Evoke Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lucy Scientific and Evoke Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lucy Scientific Discovery and Evoke Pharma, you can compare the effects of market volatilities on Lucy Scientific and Evoke Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lucy Scientific with a short position of Evoke Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lucy Scientific and Evoke Pharma.

Diversification Opportunities for Lucy Scientific and Evoke Pharma

-0.65
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Lucy and Evoke is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Lucy Scientific Discovery and Evoke Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evoke Pharma and Lucy Scientific is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lucy Scientific Discovery are associated (or correlated) with Evoke Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evoke Pharma has no effect on the direction of Lucy Scientific i.e., Lucy Scientific and Evoke Pharma go up and down completely randomly.

Pair Corralation between Lucy Scientific and Evoke Pharma

Given the investment horizon of 90 days Lucy Scientific Discovery is expected to generate 16.04 times more return on investment than Evoke Pharma. However, Lucy Scientific is 16.04 times more volatile than Evoke Pharma. It trades about 0.08 of its potential returns per unit of risk. Evoke Pharma is currently generating about -0.04 per unit of risk. If you would invest  2,990  in Lucy Scientific Discovery on August 28, 2024 and sell it today you would lose (2,988) from holding Lucy Scientific Discovery or give up 99.93% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy82.56%
ValuesDaily Returns

Lucy Scientific Discovery  vs.  Evoke Pharma

 Performance 
       Timeline  
Lucy Scientific Discovery 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lucy Scientific Discovery has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong fundamental indicators, Lucy Scientific is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders.
Evoke Pharma 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Evoke Pharma are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite quite inconsistent basic indicators, Evoke Pharma may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Lucy Scientific and Evoke Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lucy Scientific and Evoke Pharma

The main advantage of trading using opposite Lucy Scientific and Evoke Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lucy Scientific position performs unexpectedly, Evoke Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evoke Pharma will offset losses from the drop in Evoke Pharma's long position.
The idea behind Lucy Scientific Discovery and Evoke Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios